U.S. ITC Concludes Probe on Disposable E-cigarettes

Special Note: The information in this article is sourced from the internet or provided by industry insiders. Vape1024 cannot verify the authenticity of some information, which is disseminated solely for industry news and updates. Please be aware that some content may contain personal subjective opinions. Read with discretion. If you have any objections to this article, please contact me at liosunlit@gmail.com.

    Add a header to begin generating the table of contents

    The U.S. International Trade Commission (ITC) issues partial determinations in the 337 investigation (code: 337-TA-1381) regarding certain disposable e-cigarettes.

    ITC’s Determinations

    The ITC has opted not to review several initial determinations, including the termination of investigations and issuance of consent orders for companies accused of false advertising and unfair competition. Notable determinations include the termination of investigations against U.S. companies EVO Brands, LLC and PVG2, LLC, as well as China’s Guangdong Shenzhen Fu Mote Technology Co., Ltd and China’s Guangdong Shenzhen Innokin Technology Co., Ltd.

    Key Dates and Events

    The investigation stemmed from allegations by U.S. R.J. Reynolds Tobacco Company and R.J. Reynolds Vapor Company in October 2023, citing violations of U.S. Section 337 related to false advertising, fictitious origin marking, and unfair competition. The ITC’s vote in December 2023 initiated the investigation, leading to subsequent determinations.

    Implications and Significance

    These determinations underscore the U.S.’s commitment to addressing unfair competition in the imported e-cigarette market. By assessing allegations of false advertising and unfair practices, the ITC aims to uphold market integrity and competitiveness.


    As the U.S. ITC concludes its investigation into specific disposable e-cigarettes, the outcomes reflect efforts to uphold fair competition and regulatory compliance in the e-cigarette market. With termination orders and consent decrees issued, both U.S. and Chinese companies implicated in the investigation must navigate regulatory scrutiny and ensure compliance with U.S. Section 337 regulations moving forward.